<table width="85%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 11	Mean (± SD) Tenofovir Pharmacokinetic Parameters by Age Groups for HIV–1–infected Pediatric Patients</caption>
<col align="left" span="1" valign="top" width="30%"></col>
<col align="center" span="1" valign="top" width="35%"></col>
<col align="center" span="1" valign="top" width="35%"></col>
<tbody>
<tr>
<th colspan="1">Dose and Formulation</th>
<th colspan="1">300 mg Tablet</th>
<th colspan="1">8 mg/kg Oral Powder</th>
</tr>
<tr>
<th colspan="1"></th>
<th colspan="1">12 to &lt;18 Year (N=8)</th>
<th colspan="1">2 to &lt;12 Years (N=23)</th>
</tr>
<tr>
<td>C<sub>max</sub> (µg/mL)</td>
<td>0.38 ± 0.13</td>
<td>0.24 ± 0.13</td>
</tr>
<tr>
<td>AUC<sub>tau</sub> (µg<content stylecode="bold">∙</content>hr/mL)</td>
<td>3.39 ± 1.22</td>
<td>2.59 ± 1.06</td>
</tr>
</tbody>
</table>